XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Investment in RP Finance, LLC (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Oct. 31, 2021
Jul. 31, 2023
Jul. 31, 2022
Sep. 30, 2021
Jul. 31, 2021
Jun. 30, 2021
Nov. 30, 2020
Aug. 31, 2020
Feb. 03, 2020
Investment in RP Finance, LLC (Details) [Line Items]                  
Amount of revolving commitment to funds       $ 5,000 $ 10,000 $ 10,000 $ 5,000 $ 5,000  
Income from interest   $ 0 $ 1,900            
Percentage of ownership interest     37.50%            
Cumulative funds description   the Company has funded a cumulative total of $9.375 million in accordance with its 37.5% ownership interests in RP Finance.              
Rafael Pharmaceuticals [Member]                  
Investment in RP Finance, LLC (Details) [Line Items]                  
Amount of revolving commitment to funds       $ 5,000     $ 5,000 $ 5,000  
Percentage of issued and outstanding shares   12.00%              
Related party receivable     $ 9,375            
Line of Credit Agreement [Member]                  
Investment in RP Finance, LLC (Details) [Line Items]                  
Amount of revolving commitment to funds                 $ 50,000,000
Description line of credit facility   The Company owns 37.5% of the equity interests in RP Finance and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. The Instrument owns 37.5% of the equity interests in RP Finance, and is required to fund 37.5% of funding requests from Cornerstone Pharmaceuticals under the RPF Line of Credit. The remaining 25% equity interests in RP Finance are owned by other stockholders of Cornerstone Pharmaceuticals.              
RP finance [Member]                  
Investment in RP Finance, LLC (Details) [Line Items]                  
Income from interest   $ 0 $ 575            
Percentage of ownership interest   37.50% 37.50%            
Equity loss $ 575                
Equity method investment   $ 0 $ 0